hVIVO PLC (LON:HVO) shares blew higher on Thursday morning after US regulators found that its flu vaccine did achieve its primary endpoint in last year’s mid-stage clinical trial.
i3 Energy PLC (LON:i3E) shares advanced as it signed a letter of intent for a multi-well drill programme that’s intended to take the Liberator field to the cusp of production. At the same time, the ambitious North Sea oiler told investors that its received proposals regarding offtake terms for Liberator’s future production, and, provided an update about its ongoing project financing work.
Obtala Ltd (LON:OBT) has announced today a series of deals that it expects to positively impact the forestry company’s balance sheet and underlying business structure. It has agreed to sell its Tanzanian agricultural business for US$2.5mln, it is to receive £7mln of investments from a fund managed by Lombard Odier Asset Management, and, it is to take full ownership of its currently 75% owned Montara Continental subsidiary.
StatPro Group PLC (LON:SOG) has signed a contract with a UK investment manager to convert from its StatPro Seven to StatPro Revolution service in a deal worth a minimum of £1.45mln.
SigmaRoc PLC (LON:SRC) has acquired the Foelfach quarry in Carmarthenshire, South Wales, and appointed a new managing director following its general meeting on 27 December.
Loans and grants from Spanish authorities could help finance most of the commercial scale-up costs for Midatech PLC’s (LON:MTPH) Q-Sphera technology platform which it is using in its MTD201 drug program. The AIM company has a manufacturing facility in Bilbao which makes it eligible for financial backing from local and national governments.
BlueRock Diamonds PLC (LON:BRD) told investors that its sales from the Kareevlei diamond mine rose 71% to 5,805 carats for 2018. Production volumes for the full year amounted to 189,990 tonnes, up 24%, whilst the average grade increased by 34% to 3.28 carats per hundred tonnes.
Belvoir Lettings PLC (LON:BLV), the UK's largest property franchise, exceeded its 2018 target for assisted acquisitions by its franchisees. The lettings agent said beefing up the assisted acquisitions programme is a core part of its growth strategy.
InnovaDerma PLC (LON:IDP) said revisions to its direct to consumer strategy have begun to bear fruit in recent weeks. The group, which sells beauty and personal care products such as the globally successful Skinny Tan line, has faced headwinds on Facebook, which has begun prioritising personal engagement over businesses and brands.
Nigeria focused Eland Oil & Gas PLC (LON:ELA) told investors that the Gbetiokun-3 well has encountered oil-bearing reservoirs across multiple horizons and it will be completed as a producer. Eland, in a statement, confirmed the completion of the drilling of the appraisal and development well.
Greatland Gold PLC (LON:GGP) (ASX:GGP) shares gained on Thursday lifted by news Primorus Investments PLC (LON:PRIM) has increased its holding in the Australia-focused gold explorer to around 1.1%. Primorus said it now owns a total of 35m shares in the AIM-listed metals exploration company, which were acquired at a weighted average price of 1.71p per share.
Alba Mineral Resources PLC (LON:ALBA) highlighted that well operations had resumed at the Brockham oil project after operator Angus Energy Plc (LON:ANGS) released a broader investor update earlier today. Angus, in its announcement, stated that the commercial flow test programme resumed at the Brockham on 4 January.
Employee benefits provider Personal Group PLC (LON:PGH) said results for the year just ended are expected to be broadly in line with market expectations.
Aminex PLC (LON: AEX) has announced the appointment of Linda Beal as an independent non-executive director of the company with immediate effect. It said Beal is a Chartered Accountant and has over 30 years' experience with PwC including over 16 years as partner, during which time she led services to various international resources groups and advised on many transactions. The group also announced the appointment with immediate effect of GMP FirstEnergy, who will act as a joint corporate broker to the company alongside Davy, Aminex's sponsor, and Shore Capital.
Summit Therapeutics (LON: SUMM) (NASDAQ:SMMT) announced that the subscription to raise US$25mln, as approved by shareholders at the company’s general meeting on 4 January 2019, has completed. It said the subscription shares, comprising 78,125,000 new ordinary shares represented by 15,625,000 American Depositary Shares, were admitted to AIM today.